Page 40 - Roadmap
P. 40

MOMENTUM OF INNOVATION







                                      7.3. HEALTH AND FOOD SCIENCES

                 BIOINFORMATICS RESEARCH INFRASTRUCTURE GROUP, ELIXIR NETWORK,
                                 ELIXIR CONSORTIUM OF HUNGARY (ELIXIR-HU)
















        Presentation of the RI group
        Bioinformatics research in Hungary can be grouped around five main themes: human genomics (medical genomics
        and cell biology), agrigenomics, proteomics, veterinary sciences (virology) and ecology (biological networks) . Although
        members of the RI group work in different research areas, what they have in common is the integrated handling, pro-
        cessing and interpretation of large amounts of data originating from biological measurements.

        The RI’s assets enable complex studies of clinical genomics, and the results of these studies can be used in research,
        medicine and education. The most cited online softwares deal with protein structure prediction, prediction of trans-
        membrane protein topology and evaluation of the prognostic value of oncology biomarkers.

        Databases also constitute integral parts of the RI, for example the Hungarian Oncogenome Portal (human genomics),
        the database of adenovirus sequences (virology), the UniTMP databases (proteomics) and the MÉTA website (ecology).
        The RI group is also committed to the expansion of bioinformatics training services.










        National coordinator of the RI group:                    Background information
        MTA Research Centre for Natural Sciences, Institute of Enzymology (MTA   The national coordinator of the RI group (and of the Hungarian
        TTK EI)                                                  ELIXIR Node to be implemented) is the Institute of Enzymology
                                                                 of MTA TTK. The RI group consists of intensely cooperating Hun-
        Contact: László Patthy                                   garian universities and research institutions that play a leading role
        Email: patthy.laszlo@ttk.mta.hu                          in life sciences in Hungary. Members of the RI group participate in
        Website: http://www.ttk.mta.hu/                          major international research programmes such as the Joint Action
                                                                 on Rare Cancers, COMPARE, ECRIN, EMBnet and eLTER RI.
        Partners:                                                The portfolio of equipments (next-generation sequencing systems,
        Eötvös Loránd University (ELTE), University of Debrecen (DE), Semmel-  high performance computing infrastructure) has been renewed by
        weis University (SE), Szentágothai Research Centre, University of  Pécs   major investments and continuous progress in software and database
        (PTE); University of Veterinary Medicine (ÁTE), Pázmány Péter Catholic   development is a hallmark of the development of the RI.
        University (PPKE), National Institute of Oncology (OOI), National Agri-
        cultural Research and Innovation Centre (NAIK), MTA Centre for Ecolo-  Aim of the RI group
        gical Research (MTA ÖK), MTA Alfréd Rényi Institute of Mathematics   The aim of the RI group is to promote the application and advance
        (MTA RAMKI), Institute for Veterinary Medical Research, MTA Centre   of bioinformatics in all areas of life sciences in Hungary. It strives
        for Agricultural Research,  (MTA ATK ÁOTI)               to join international programmes as a full-fledged member of
                                                                 ELIXIR and to provide Hungarian bioinformatics services to the
        ESFRI connection: ELIXIR                                 international scientific community. The ELIXIR membership is
                                                                 expected to boost international research cooperation and this will
        Status of the RI group: under implementation             require further significant investments in the bioinformatics RI.


                                                            40
   35   36   37   38   39   40   41   42   43   44   45